Changes to physical function and body composition during the first 2 years of polymyalgia rheumatica. [PDF]
Leung JL +8 more
europepmc +1 more source
Correction: The DANIsh VASculitis cohort study: protocol for a national multicenter prospective study including incident and prevalent patients with giant cell arteritis and polymyalgia rheumatica. [PDF]
Nielsen BD +11 more
europepmc +1 more source
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica. [PDF]
Chevet B +24 more
europepmc +1 more source
Mitochondrial-Mediated Platelet Activation in Polymyalgia Rheumatica. [PDF]
Michailidou D +7 more
europepmc +1 more source
Polymyalgia Rheumatica Mimicking Infection and Malignancy: A Diagnostic Challenge Ruled Out by PET-CT. [PDF]
Aung MW +5 more
europepmc +1 more source
Polymyalgia Rheumatica Presenting as Fever of Unknown Origin. [PDF]
Shiba H, Ozawa H, Okada M.
europepmc +1 more source
Predictors of giant cell arteritis in patients with polymyalgia rheumatica in southern Sweden-a retrospective study. [PDF]
Fors C +3 more
europepmc +1 more source
Oral Steroid Pulse Therapy for Polymyalgia Rheumatica. [PDF]
Inokuma S +7 more
europepmc +1 more source
Monocytes/Macrophages in Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum Disease. [PDF]
Guo J, He Y, Yang F, Chen W.
europepmc +1 more source
Immune checkpoint inhibitor associated vasculitis and polymyalgia rheumatica: a case series and systematic review. [PDF]
Teel A +8 more
europepmc +1 more source

